Ularitide for the treatment of acute decompensated heart failure: from preclinical to clinical studies

The short- and long-term morbidity and mortality in acute heart failure is still unacceptably high. There is an unmet need for new therapy options with new drugs with a new mode of action. One of the drugs currently in clinical testing in Phase III is ularitide, which is the chemically synthesized f...

Descripción completa

Detalles Bibliográficos
Autores principales: Anker, Stefan D., Ponikowski, Piotr, Mitrovic, Veselin, Peacock, W. Frank, Filippatos, Gerasimos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368857/
https://www.ncbi.nlm.nih.gov/pubmed/25670819
http://dx.doi.org/10.1093/eurheartj/ehu484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368857/
https://www.ncbi.nlm.nih.gov/pubmed/25670819
http://dx.doi.org/10.1093/eurheartj/ehu484

Ejemplares similares